Oncolytics (ONCY) Biotech announced the appointment of Andrew Aromando as Chief Business Officer. Aromando most recently served as COO at Ambrx Biopharma.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.